TWD 16.9
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 601.47 Million TWD | 0.84% |
2022 | 596.47 Million TWD | 17.4% |
2021 | 508.08 Million TWD | 4.71% |
2020 | 485.24 Million TWD | 10.55% |
2019 | 438.95 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 549.45 Million TWD | -8.65% |
2024 Q2 | 549.45 Million TWD | 0.0% |
2023 Q3 | 601.47 Million TWD | -0.71% |
2023 FY | 601.47 Million TWD | 0.84% |
2023 Q1 | 605.77 Million TWD | 1.56% |
2023 Q2 | 605.77 Million TWD | 0.0% |
2023 Q4 | 601.47 Million TWD | 0.0% |
2022 Q4 | 596.47 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | -286.965% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -1326.276% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 45.119% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 62.366% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 45.111% |
Center Laboratories, Inc. | 269.22 Million TWD | -123.407% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -693.545% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | -157.071% |
InnoPharmax Inc. | 22.24 Million TWD | -2604.109% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | -333.317% |
Excelsior Biopharma Inc. | 217.28 Million TWD | -176.819% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -523.193% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -374.353% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -1978.065% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | -111.891% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -419.696% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -5870.568% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -975.022% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -408.024% |